Is NEVIF or MRK a better dividend investment in 2026?

NEVIF currently yields 6060.61% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: NEVIF offers higher current income.

What is the dividend yield difference between NEVIF and MRK?

NEVIF has a forward dividend yield of 6060.61% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 6057.85 percentage points.

Home › Compare › NEVIF vs MRK

NEVIF vs MRK: Dividend Comparison 2026

NEVIF yields 6060.61% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NEVIF wins by $405051483993510.75M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NEVIF

● Live price

6060.61%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$405051483993510.81M

Annual income

$392,317,639,085,937,900,000.00

Full NEVIF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — NEVIF vs MRK

📍 NEVIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NEVIF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NEVIF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NEVIF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEVIF

Annual income on $10K today (after 15% tax)

$515,151.52/yr

After 10yr DRIP, annual income (after tax)

$333,469,993,223,047,200,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, NEVIF beats the other by $333,469,993,223,047,200,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEVIF + MRK for your $10,000?

NEVIF: 50%MRK: 50%

100% MRK50/50100% NEVIF

Portfolio after 10yr

$202525741996755.44M

Annual income

$196,158,819,542,968,960,000.00/yr

Blended yield

96.86%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NEVIF

No analyst data

Altman Z

-10.2

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEVIF buys

MRK buys

No recent congressional trades found for NEVIF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNEVIFMRK

Forward yield	6060.61% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$405051483993510.81M ✓	$56.8K
Annual income after 10y	$392,317,639,085,937,900,000.00 ✓	$9,798.13
Total dividends collected	$404194901711197.88M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NEVIF vs MRK ($10,000, DRIP)

Year	NEVIF Portfolio	NEVIF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$616,761	$606,060.61	$11,206	$366.19	+$605.6K → NEVIF
2	$35,593,981	$34,934,047.36	$12,650	$502.35	+$35.58M → NEVIF
3	$1,922,277,177	$1,884,191,616.78	$14,407	$694.19	+$1922.26M → NEVIF
4	$97,156,883,737	$95,100,047,158.43	$16,585	$967.82	+$97156.87M → NEVIF
5	$4,596,110,678,979	$4,492,152,813,380.20	$19,342	$1,363.89	+$4596110.66M → NEVIF
6	$203,521,680,456,176	$198,603,842,029,668.53	$22,913	$1,947.19	+$203521680.43M → NEVIF
7	$8,436,864,510,211,879	$8,219,096,312,123,770.00	$27,662	$2,823.89	+$8436864510.18M → NEVIF
8	$327,455,032,665,303,300	$318,427,587,639,376,600.00	$34,159	$4,173.35	+$327455032665.27M → NEVIF
9	$11,900,789,633,245,725,000	$11,550,412,748,293,850,000.00	$43,337	$6,308.80	+$11900789633245.68M → NEVIF
10	$405,051,483,993,510,840,000	$392,317,639,085,937,900,000.00	$56,776	$9,798.13	+$405051483993510.75M → NEVIF

NEVIF vs MRK: Complete Analysis 2026

NEVIF — Stock

Nevis Brands Inc. engages in the development and sale of cannabis products in the United States. The company offers hemp derived THC beverages under the Major brand name. The company was formerly known as Pascal Biosciences Inc. and changed its name to Nevis Brands Inc. in June 2023. Nevis Brands Inc. is headquartered in Seattle, Washington.

Full NEVIF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this NEVIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEVIF vs SCHD NEVIF vs JEPI NEVIF vs O NEVIF vs KO NEVIF vs MAIN NEVIF vs JNJ NEVIF vs ABBV NEVIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.